{"id":49295,"date":"2022-10-06T19:01:58","date_gmt":"2022-10-06T17:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/"},"modified":"2022-10-06T19:01:58","modified_gmt":"2022-10-06T17:01:58","slug":"samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/","title":{"rendered":"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America"},"content":{"rendered":"
\n

\nUsing a segmented approach, the company has developed two new roles to provide stellar service to all markets served.<\/b>\n<\/p>\n

DANVERS, Mass.–(BUSINESS WIRE)–To maximize patient and customer reach with our best-in-class imaging technology, Samsung has made the decision to increase its investment in the ultrasound business in North America. From investing in new product introductions featuring Samsung technology to order processing system improvements; expanding service offerings to include remote automation, and expansion of market coverage to reach more Integrated Delivery Networks. These investments are focused on assuring our patients and clinicians have easier access to our innovative imaging technology.\n<\/p>\n

<\/a><\/p>\n

\n\u201cAs Samsung’s business in the United States continues to grow, we feel the need to segment the ultrasound business to better accommodate our customers’ growing needs. Adding leadership talent with a depth of market knowledge and experience in key segments is necessary to accomplish this,\u201d according to David Legg, Head of Boston Imaging, the healthcare subsidiary of Samsung. \u201cWhile our Senior Director Dan Monaghan will continue to lead our General Imaging, Point-of-Care and Veterinary Ultrasound businesses, I am pleased to announce today the appointment of Tracy Bury to the newly created role of Women’s Health Ultrasound Business Leader, where she will lead efforts in the Maternal-Fetal Medicine, Assisted Reproductive Medicine and Obstetrics and Gynecology markets.\u201d The company is focused on delivering life-long healthcare solutions for women and using Samsung’s excellent image quality, ergonomics and artificial intelligence (AI) assisted software, which assists clinicians in diagnosing and developing optimal treatment paths for this patient population.\n<\/p>\n

\nTracy joins Samsung after a stellar career as an executive leading the U.S. Women’s Health business at GE Healthcare and leading global ultrasound teams for Siemens Healthineers. She brings 25+ years of experience and solid industry relationships that will benefit Boston Imaging\u2019s Women\u2019s Health business. With her joining, Boston Imaging will continue to deepen KOL relationships and recruit top talents from the market to better serve customers’ needs. “I’m excited to be a part of the Samsung vision of segmenting the ultrasound business, enabling us to provide dedicated people, products and processes to address the specific needs of Women’s Health patients and clinicians,” said Tracy Bury, Women’s Health Ultrasound Business Leader, Boston Imaging. Tracy’s leadership will be key to delivering the Samsung imaging technology message to this vitally important market.\n<\/p>\n

\nThis segmented focus of both Women\u2019s Health and Radiology ultrasound business units will drive faster technology adoption through a greater understanding of the specific patient population and clinical markets served.\n<\/p>\n

\nThrough its network of dealers and direct associates in North America, Samsung provides best-in-class ultrasound technology for Women’s Health, Radiology, Point-of-Care and Veterinary businesses. Additionally, in its separate digital radiography business, Samsung provides advanced digital X-ray technology including portable, panel and fixed room technology.\n<\/p>\n

\nTo learn more about Boston Imaging, please visit bostonimaging.com<\/b><\/a>\n<\/p>\n

\nAbout Samsung Electronics Co., Ltd.<\/span><\/b>\n<\/p>\n

\nSamsung inspires the world and shapes the future with transformative ideas and technologies. The company is redefining the worlds of TVs, smartphones, wearable devices, tablets, digital appliances, network systems and memory, system LSI, foundry and LED solutions. For the latest news, please visit the Samsung Newsroom at http:\/\/news.samsung.com<\/b><\/a>\n<\/p>\n

\nAbout Boston Imaging<\/span><\/b>\n<\/p>\n

\nBoston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the United States headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging\u2019s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit https:\/\/www.bostonimaging.com\/<\/b><\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Inquiries<\/b>
Lynne Gagne
\n
Boston Imaging
\n
978.564.8576
\n
lgagne@bostonimaging.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Using a segmented approach, the company has developed two new roles to provide stellar service to all markets served. DANVERS, Mass.–(BUSINESS WIRE)–To maximize patient and customer reach with our best-in-class imaging technology, Samsung has made the decision to increase its investment in the ultrasound business in North America. From investing in new product introductions featuring … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49295","6":"format-standard","7":"category-industry"},"yoast_head":"\nSamsung Continues to Make Significant Investment in its Ultrasound Business in North America - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Using a segmented approach, the company has developed two new roles to provide stellar service to all markets served. DANVERS, Mass.–(BUSINESS WIRE)–To maximize patient and customer reach with our best-in-class imaging technology, Samsung has made the decision to increase its investment in the ultrasound business in North America. From investing in new product introductions featuring ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-06T17:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221005005142\/en\/1592102\/21\/BI_Logo_Color.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America\",\"datePublished\":\"2022-10-06T17:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/\"},\"wordCount\":638,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005142\\\/en\\\/1592102\\\/21\\\/BI_Logo_Color.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/\",\"name\":\"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005142\\\/en\\\/1592102\\\/21\\\/BI_Logo_Color.jpg\",\"datePublished\":\"2022-10-06T17:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005142\\\/en\\\/1592102\\\/21\\\/BI_Logo_Color.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221005005142\\\/en\\\/1592102\\\/21\\\/BI_Logo_Color.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/","og_locale":"en_US","og_type":"article","og_title":"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America - Pharma Trend","og_description":"Using a segmented approach, the company has developed two new roles to provide stellar service to all markets served. DANVERS, Mass.–(BUSINESS WIRE)–To maximize patient and customer reach with our best-in-class imaging technology, Samsung has made the decision to increase its investment in the ultrasound business in North America. From investing in new product introductions featuring ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-06T17:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221005005142\/en\/1592102\/21\/BI_Logo_Color.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America","datePublished":"2022-10-06T17:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/"},"wordCount":638,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221005005142\/en\/1592102\/21\/BI_Logo_Color.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/","url":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/","name":"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221005005142\/en\/1592102\/21\/BI_Logo_Color.jpg","datePublished":"2022-10-06T17:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221005005142\/en\/1592102\/21\/BI_Logo_Color.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221005005142\/en\/1592102\/21\/BI_Logo_Color.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/samsung-continues-to-make-significant-investment-in-its-ultrasound-business-in-north-america\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Samsung Continues to Make Significant Investment in its Ultrasound Business in North America"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49295"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49295\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}